GB8814727D0 - Medicaments - Google Patents

Medicaments

Info

Publication number
GB8814727D0
GB8814727D0 GB888814727A GB8814727A GB8814727D0 GB 8814727 D0 GB8814727 D0 GB 8814727D0 GB 888814727 A GB888814727 A GB 888814727A GB 8814727 A GB8814727 A GB 8814727A GB 8814727 D0 GB8814727 D0 GB 8814727D0
Authority
GB
United Kingdom
Prior art keywords
medicaments
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB888814727A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to GB888814727A priority Critical patent/GB8814727D0/en
Publication of GB8814727D0 publication Critical patent/GB8814727D0/en
Priority to GB8913876A priority patent/GB2219939A/en
Pending legal-status Critical Current

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nanotechnology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB888814727A 1988-06-21 1988-06-21 Medicaments Pending GB8814727D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GB888814727A GB8814727D0 (en) 1988-06-21 1988-06-21 Medicaments
GB8913876A GB2219939A (en) 1988-06-21 1989-06-16 Use of a thromboxane receptor antagonist in renal diseases and dysfunction

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888814727A GB8814727D0 (en) 1988-06-21 1988-06-21 Medicaments

Publications (1)

Publication Number Publication Date
GB8814727D0 true GB8814727D0 (en) 1988-07-27

Family

ID=10639067

Family Applications (2)

Application Number Title Priority Date Filing Date
GB888814727A Pending GB8814727D0 (en) 1988-06-21 1988-06-21 Medicaments
GB8913876A Withdrawn GB2219939A (en) 1988-06-21 1989-06-16 Use of a thromboxane receptor antagonist in renal diseases and dysfunction

Family Applications After (1)

Application Number Title Priority Date Filing Date
GB8913876A Withdrawn GB2219939A (en) 1988-06-21 1989-06-16 Use of a thromboxane receptor antagonist in renal diseases and dysfunction

Country Status (1)

Country Link
GB (2) GB8814727D0 (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6422863A (en) * 1987-06-22 1989-01-25 Glaxo Group Ltd Aminocyclopentyl ether, manufacture and medicinal composition

Also Published As

Publication number Publication date
GB2219939A (en) 1989-12-28
GB8913876D0 (en) 1989-08-02

Similar Documents

Publication Publication Date Title
GB8819477D0 (en) Medicaments
GB8905400D0 (en) Medicaments
ZA895142B (en) Medicaments
GB8805269D0 (en) Medicaments
ZA891640B (en) Medicaments
GB8814726D0 (en) Medicaments
GB8820651D0 (en) Medicaments
GB8808599D0 (en) Medicaments
GB8820650D0 (en) Medicaments
GB8814725D0 (en) Medicaments
GB8820653D0 (en) Medicaments
GB8911166D0 (en) Medicaments
GB8828032D0 (en) Medicaments
GB8814053D0 (en) Medicaments
GB8814728D0 (en) Medicaments
GB8819707D0 (en) Medicaments
GB8819480D0 (en) Medicaments
GB8819479D0 (en) Medicaments
GB8822071D0 (en) Medicaments
GB8825392D0 (en) Medicaments
GB8826287D0 (en) Medicaments
GB8826288D0 (en) Medicaments
GB8826394D0 (en) Medicaments
GB8827007D0 (en) Medicaments
GB8819478D0 (en) Medicaments